Literature DB >> 718142

HLA antigens in the Landry-Guillain-Barré syndrome and chronic relapsing polyneuritis.

G J Stewart, J D Pollard, J G McLeod, C M Wolnizer.   

Abstract

Forty-four patients with inflammatory demyelinating polyneuritis (22 with Landry-Guillain-Barré syndrome, 6 with subacute polyneuritis, and 16 with chronic relapsing polyneuritis) were typed for genetic markers in and around the HLA region of chromosome 6. Patients with chronic relapsing polyneuritis showed a definite association with HLA-AW30 and AW31 and probable associations with HLA-B8, HLA-DW3, and glyoxalase I. No significant associations were demonstrated with the Landry-Guillain-Barré syndrome although an increase in glyoxalase I was significant if combined with the results of typing in chronic relapsing polyneuritis. The total patient group showed significant increases in HLA-AW30, HLA-AW31, and HLA-DW3. The results support the view that HLA-linked genetic factors influence susceptibility to chronic relapsing polyneuritis and may contribute to the differences in clinical patterns observed in inflammatory demyelination of the peripheral nervous system.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 718142     DOI: 10.1002/ana.410040317

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

Review 1.  Management of chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Richard A C Hughes
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  HLA antigens in chronic inflammatory demyelinating polyneuropathy.

Authors:  D J Feeney; J D Pollard; J G McLeod; G J Stewart; T J Doran
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

3.  Chronic inflammatory demyelinating polyneuropathy in two siblings.

Authors:  A A Gabreëls-Festen; A T Hageman; F J Gabreëls; E M Joosten; W O Renier; C M Weemaes; H J ter Laak
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-02       Impact factor: 10.154

Review 4.  Immunology of Guillain-Barré syndrome.

Authors:  I Steiner; O Abramsky
Journal:  Springer Semin Immunopathol       Date:  1985

5.  HLA antigens in chronic relapsing idiopathic inflammatory polyneuropathy.

Authors:  D Adams; H Festenstein; J D Gibson; R A Hughes; J Jaraquemada; C Papasteriadis; J Sachs; P K Thomas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-02       Impact factor: 10.154

6.  Acute inflammatory polyradiculoneuropathy following type A viral hepatitis.

Authors:  C L Johnston; M Schwartz; M H Wansbrough-Jones
Journal:  Postgrad Med J       Date:  1981-10       Impact factor: 2.401

7.  The epidemiology of inflammatory polyradiculoneuropathy. A critical review of the distribution, characteristics and outcome of the disease. Plasmapheresis Study Group.

Authors:  E Beghi; F Cornelio; M Marconi; N Rizzuto; P Tonali
Journal:  Ital J Neurol Sci       Date:  1991-02

8.  Appearance of Guillain-Barré syndrome in patients during corticosteroid treatment.

Authors:  I Steiner; I Wirguin; O Abramsky
Journal:  J Neurol       Date:  1986-08       Impact factor: 4.849

Review 9.  Campylobacter species and Guillain-Barré syndrome.

Authors:  I Nachamkin; B M Allos; T Ho
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

Review 10.  Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events.

Authors:  Esmée P Hoefsmit; Elisa A Rozeman; John B A G Haanen; Christian U Blank
Journal:  ESMO Open       Date:  2019-07-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.